Jeonjinbio Statistics

Total Valuation

Jeonjinbio has a market cap or net worth of KRW 36.33 billion. The enterprise value is 30.30 billion.

Market Cap	36.33B
Enterprise Value	30.30B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

Jeonjinbio has 9.06 million shares outstanding. The number of shares has increased by 18.81% in one year.

Current Share Class	9.06M
Shares Outstanding	9.06M
Shares Change (YoY)	+18.81%
Shares Change (QoQ)	+0.74%
Owned by Insiders (%)	6.84%
Owned by Institutions (%)	3.99%
Float	7.94M

Valuation Ratios

The trailing PE ratio is 8.41.

PE Ratio	8.41
Forward PE	n/a
PS Ratio	2.13
PB Ratio	2.10
P/TBV Ratio	2.10
P/FCF Ratio	21.12
P/OCF Ratio	18.48
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 19.12, with an EV/FCF ratio of 17.61.

EV / Earnings	7.14
EV / Sales	1.78
EV / EBITDA	19.12
EV / EBIT	53.87
EV / FCF	17.61

Financial Position

The company has a current ratio of 10.87

Current Ratio	10.87
Quick Ratio	9.00
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	2.96

Financial Efficiency

Return on equity (ROE) is 32.26% and return on invested capital (ROIC) is 2.40%.

Return on Equity (ROE)	32.26%
Return on Assets (ROA)	1.94%
Return on Invested Capital (ROIC)	2.40%
Return on Capital Employed (ROCE)	3.23%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.94
Inventory Turnover	7.12

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +14.74% in the last 52 weeks. The beta is -0.96, so Jeonjinbio's price volatility has been lower than the market average.

Beta (5Y)	-0.96
52-Week Price Change	+14.74%
50-Day Moving Average	2,635.00
200-Day Moving Average	2,625.72
Relative Strength Index (RSI)	75.34
Average Volume (20 Days)	380,086

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Jeonjinbio had revenue of KRW 17.02 billion and earned 4.25 billion in profits. Earnings per share was 476.66.

Revenue	17.02B
Gross Profit	4.93B
Operating Income	562.43M
Pretax Income	4.25B
Net Income	4.25B
EBITDA	1.58B
EBIT	562.43M
Earnings Per Share (EPS)	476.66

Full Income Statement

Balance Sheet

The company has 6.03 billion in cash and n/a in debt, giving a net cash position of 6.03 billion or 665.63 per share.

Cash & Cash Equivalents	6.03B
Total Debt	n/a
Net Cash	6.03B
Net Cash Per Share	665.63
Equity (Book Value)	17.28B
Book Value Per Share	1,907.33
Working Capital	8.54B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.97 billion and capital expenditures -245.63 million, giving a free cash flow of 1.72 billion.

Operating Cash Flow	1.97B
Capital Expenditures	-245.63M
Free Cash Flow	1.72B
FCF Per Share	189.89

Full Cash Flow Statement

Margins

Gross margin is 28.98%, with operating and profit margins of 3.30% and 24.94%.

Gross Margin	28.98%
Operating Margin	3.30%
Pretax Margin	24.94%
Profit Margin	24.94%
EBITDA Margin	9.31%
EBIT Margin	3.30%
FCF Margin	10.11%

Dividends & Yields

Jeonjinbio does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-18.81%
Shareholder Yield	n/a
Earnings Yield	11.69%
FCF Yield	4.74%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Jeonjinbio has an Altman Z-Score of 17.92 and a Piotroski F-Score of 4.

Altman Z-Score	17.92
Piotroski F-Score	4